Boehringer Ingelheim Vetmedica GmbH

Company Premium

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

 

Send message
Serum and oral fluid PRRSV qRT-PCR results by post-inoculation week

Oral fluids in PRRS diagnosis

29-May-2015

Diagnosis in oral fluids is indicated for the control of replacements on arrival and after the adaptation process, and of the different production batches, especially risk subpopulations such as animals with a slow growth rate.

PRRS

Transmission routes, control and prevention of PRRS

30-Jan-2015

PRRS virus infection can be considered common in areas of high pig density and, in such cases, the idea that biosecurity and can do little is widespread. However, proper biosecurity measures must be implemented in order to prevent the introduction of new strains.

Contact:

Contact us using the following form.

Boehringer Ingelheim Vetmedica GmbH is present in the following categories